Pyung Gang Ato Soon
NDC Package 69698-2001-1
Package Information
Pyung Gang Ato Soon is a medication used as Skin Protectant. Marketed by Pyung Gang Oriental Medical Clinic, this product is identified by NDC 69698-2001.
Identification & Billing
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 69698 - Pyung Gang Oriental Medical Clinic
- 69698-2001 - Pyung Gang Ato Soon
- 69698-2001-1 - 120 mL in 1 BOTTLE
- 69698-2001 - Pyung Gang Ato Soon
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 69698-2001-1 identifies a specific commercial package of 120 ml in 1 bottle of Pyung Gang Ato Soon, labeled by Pyung Gang Oriental Medical Clinic. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Pyung Gang Oriental Medical Clinic on April 02, 2015. The current certification is valid through December 31, 2018.
How is this Pyung Gang Oriental Medical Clinic product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 69698200101. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.